Royal Bank of Canada’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.94M Sell
27,000
-528,800
-95% -$40.7M ﹤0.01% 3121
2025
Q4
$44.1M Buy
555,800
+322,400
+138% +$25.4M 0.01% 1009
2025
Q3
$17.6M Buy
233,400
+33,400
+17% +$2.29M ﹤0.01% 1746
2025
Q2
$13.8M Hold
200,000
﹤0.01% 1795
2025
Q1
$13.6M Sell
200,000
-2,200
-1% -$132K ﹤0.01% 1564
2024
Q4
$9.08M Buy
202,200
+96,700
+92% +$5.42M ﹤0.01% 1863
2024
Q3
$6.63M Buy
105,500
+102,000
+2,914% +$5.95M ﹤0.01% 2062
2024
Q2
$207K Buy
+3,500
New +$219K ﹤0.01% 4741
2023
Q3
Sell
-150,400
Closed -$10.4M 7157
2023
Q2
$10.4M Buy
150,400
+150,000
+37,500% +$10.7M ﹤0.01% 1556
2023
Q1
$30K Sell
400
-109,100
-100% -$9.15M ﹤0.01% 5864
2022
Q4
$10.2M Buy
109,500
+20,400
+23% +$1.97M ﹤0.01% 1584
2022
Q3
$8.5M Hold
89,100
﹤0.01% 1659
2022
Q2
$8.26M Buy
89,100
+22,500
+34% +$2.2M ﹤0.01% 1693
2022
Q1
$6.74M Sell
66,600
-379,200
-85% -$39.8M ﹤0.01% 2011
2021
Q4
$46M Hold
445,800
0.01% 873
2021
Q3
$37.8M Buy
445,800
+210,000
+89% +$17.6M 0.01% 905
2021
Q2
$19.7M Buy
235,800
+196,600
+502% +$16.1M 0.01% 1359
2021
Q1
$2.95M Sell
39,200
-130,800
-77% -$9.53M ﹤0.01% 2688
2020
Q4
$11.6M Buy
170,000
+30,000
+21% +$1.95M ﹤0.01% 1609
2020
Q3
$8.18M Sell
140,000
-15,000
-10% -$933K ﹤0.01% 1675
2020
Q2
$10.1M Sell
155,000
-125,000
-45% -$7.87M ﹤0.01% 1467
2020
Q1
$16.6M Sell
280,000
-154,400
-36% -$10.3M 0.01% 1016
2019
Q4
$32.3M Buy
434,400
+72,700
+20% +$5.1M 0.01% 855
2019
Q3
$22.8M Buy
361,700
+228,300
+171% +$13.5M 0.01% 1003
2019
Q2
$7.27M Buy
133,400
+129,300
+3,154% +$6.96M ﹤0.01% 1799
2019
Q1
$221K Sell
4,100
-125,600
-97% -$7.75M ﹤0.01% 4291
2018
Q4
$8.5M Buy
129,700
+123,400
+1,959% +$9.21M ﹤0.01% 1608
2018
Q3
$496K Sell
6,300
-128,700
-95% -$9.2M ﹤0.01% 3905
2018
Q2
$8.69M Buy
+135,000
New +$8.9M ﹤0.01% 1631
2018
Q1
Sell
-22,500
Closed -$1.63M 6412
2017
Q4
$1.63M Sell
22,500
-39,000
-63% -$2.84M ﹤0.01% 2891
2017
Q3
$5M Buy
61,500
+39,000
+173% +$3.08M ﹤0.01% 1991
2017
Q2
$1.81M Sell
22,500
-55,100
-71% -$4.35M ﹤0.01% 2666
2017
Q1
$6.09M Sell
77,600
-4,900
-6% -$391K ﹤0.01% 1791
2016
Q4
$6.51M Hold
82,500
﹤0.01% 1775
2016
Q3
$7.34M Sell
82,500
-43,500
-35% -$4.11M ﹤0.01% 1679
2016
Q2
$12.1M Buy
126,000
+120,000
+2,000% +$12M 0.01% 1324
2016
Q1
$622K Sell
6,000
-6,000
-50% -$583K ﹤0.01% 3463
2015
Q4
$1.17M Hold
12,000
﹤0.01% 2984
2015
Q3
$1.16M Buy
+12,000
New +$1.26M ﹤0.01% 2737
2013
Q3
Sell
-2,000
Closed -$114K 6113
2013
Q2
$114K Buy
+2,000
New +$116K ﹤0.01% 4234

Other funds holding CVS

Royal Bank of Canada's CVS Position: Q1 2026 in Review

Royal Bank of Canada reduced its CVS Health (CVS) stake by 3% in Q1 2026, selling an estimated $21.3M and leaving 8,984,614 shares worth $645M. The position accounts for 0.11% of the portfolio, ranked #173.

Royal Bank of Canada first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.56B in Q4 2021. 1,874 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Royal Bank of Canada held 8,984,614 shares of CVS Health worth $645M as of Q1 2026.
  • Royal Bank of Canada sold 276,841 CVS Health shares in Q1 2026, an estimated $21.3M.
  • CVS Health made up 0.11% of Royal Bank of Canada's portfolio in Q1 2026, its #173 holding.
  • Royal Bank of Canada first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's CVS Health position peaked at $1.56B in Q4 2021.
  • 1,874 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.